[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Malihe Mahmoudinia\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":66},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":4},"100593202",false,"NCT07003373","Comparison of Two Protocols in Frozen Embryo Transfer","Comparison of the Pregnancy Outcomes of Frozen Embryo Transfer in the Natural Cycle vs. Artificial Cycle","Inclusion Criteria:\n\nRegular menstrual cycles\n\nMaternal age between 18 and 42 years\n\nNormal intrauterine cavity confirmed by pretreatment ultrasound or hysteroscopy\n\nBody Mass Index (BMI) less than 30 kg\u002Fm²\n\nNo ovulation disorders\n\nExclusion Criteria:\n\nNo embryos available for transfer (no embryo thawing)\n\nWithdrawal of patient consent to continue treatment\n\nFailure of dominant follicle development (in natural cycle group)\n\nInadequate endometrial response for transfer\n\nNo endometriosis grade 3 or higher\n\nThe participant provided written informed consent",true,"FEMALE","18 Years","42 Years",{"count":20,"type":21},112,"ESTIMATED","INTERVENTIONAL",[24],"NA","This randomized clinical trial evaluates two different endometrial preparation protocols-hormone replacement therapy (HRT) and natural cycle-for frozen embryo transfer (FET) in infertile women undergoing assisted reproductive technology (ART). The goal is to compare implantation, clinical pregnancy, and ongoing pregnancy outcomes.",[27],"IVF Outcomes",[29,30,31],"Natural cycle","Artificial cycle","Frozen embryo transfer","NOT_YET_RECRUITING","2025-05-25",{"date":35,"type":36},"2025-06-04","ACTUAL",{"date":38,"type":21},"2025-07-05",{"date":40,"type":21},"2026-07-05",{"name":42,"class":43},"Malihe Mahmoudinia","OTHER",{"id":45,"slug":4,"hasResults":10,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":15,"sex":16,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":4,"studyType":22,"phases":54,"briefSummary":55,"conditions":56,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":63,"leadSponsor":65,"locationsCount":4},"100575246","NCT06769789","Evaluation of Pregnancy Outcome with Usage of Drug-free In-vitro Activation of Follicles Ovary","Evaluation of Pregnancy Outcome in Poor Responder Patients in IVF Cycle with Usage of Drug-free In-vitro Activation of Follicles Ovary","Inclusion Criteria:\n\n* Women under 35 years of age who have one of the following characteristics:\n\nOr poor response to gonadotropins in a previous IVF cycle (fewer than 3 oocytes in a previous IVF cycle)\n\nOr ovarian reserve test AMH less than 1.1\n\nExclusion Criteria:\n\n* Unwillingness to continue working with the researcher during the procedure","21 Years","35 Years",{"count":53,"type":21},23,[24],"This study is the pilot study to evaluate the effect of Drug-free in vitro activation to improve the outcomes of IVF in poor responder women",[57,58],"Infertility (IVF Patients)","Infertile Females or Females with Ovarian Insufficiency","2025-01-07",{"date":61,"type":36},"2025-01-10",{"date":61,"type":21},{"date":64,"type":21},"2027-01-10",{"name":42,"class":43},""]